{"id":"W2565568829","doi":"10.1182/blood.v104.11.3619.3619","title":"Phase III Evaluation of Once-Daily, Oral Therapy with ICL670 (Exjade®) Versus Deferoxamine in Patients with β-Thalassemia and Transfusional Hemosiderosis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Deferasirox; Hemosiderosis; Medicine; Deferoxamine; Thalassemia; Randomized controlled trial; Liver biopsy; Beta thalassemia; Pediatrics; Internal medicine; Gastroenterology; Surgery; Biopsy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00112328,0.001120339,0.002106274,0.0003575128,0.000341173,0.0008711212,0.0008649783,0.001240613,0.003574048],"category_scores_gemma":[0.001026007,0.0005544432,0.001104884,0.0003287675,0.0008996367,0.0006233013,0.0002415854,0.002465553,0.0007692035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007510691,"about_ca_system_score_gemma":0.001384863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001256447,"about_ca_topic_score_gemma":0.002072898,"domain_scores_codex":[0.9996742,0.0001625941,0.00001316447,0.00005059236,0.00002634025,0.00007323829],"domain_scores_gemma":[0.9990947,0.0001971957,0.000146548,0.00005785355,0.00005920721,0.0004445808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9091882,0.03389085,0.001328431,0.0004069898,0.0005574466,0.00008837012,0.000128353,0.0009177211,0.01550364,0.0001814706,0.001360755,0.0364478],"study_design_scores_gemma":[0.6873573,0.3063497,0.002952512,0.00002417453,0.0002309755,0.00007759048,0.00003672084,0.0006322115,0.001350323,0.00009429213,0.0008802746,0.0000138469],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920059,0.002159926,0.0005725353,0.0004602348,0.0001885365,0.002068287,0.0009138223,0.0000913509,0.001539423],"genre_scores_gemma":[0.989731,0.001635388,0.001499732,0.0008404099,0.0001955392,0.002179789,0.001526246,0.00002358699,0.002368448],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003574048,"threshold_uncertainty_score":0.01195639,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01917739710129839,"score_gpt":0.2702377027777295,"score_spread":0.2510603056764311,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}